Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001558370-25-006013
Filing Date
2025-04-30
Accepted
2025-04-30 16:31:20
Documents
17
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A tmb-20241231x10ka.htm   iXBRL 10-K/A 659627
2 EX-31.3 tmb-20241231xex31d3.htm EX-31.3 4682
3 EX-31.4 tmb-20241231xex31d4.htm EX-31.4 6542
  Complete submission text file 0001558370-25-006013.txt   1070834

Data Files

Seq Description Document Type Size
4 EX-101.SCH tmb-20241231.xsd EX-101.SCH 4853
5 EX-101.DEF tmb-20241231_def.xml EX-101.DEF 37722
6 EX-101.LAB tmb-20241231_lab.xml EX-101.LAB 27126
7 EX-101.PRE tmb-20241231_pre.xml EX-101.PRE 17476
19 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20241231x10ka_htm.xml XML 17554
Mailing Address 12 PENNS TRAIL NEWTOWN PA 18940
Business Address 12 PENNS TRAIL NEWTOWN PA 18940 267-759-3680
Traws Pharma, Inc. (Filer) CIK: 0001130598 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36020 | Film No.: 25895981
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)